Assisted innovator drug company in acquisition requiring expedited review of patent and exclusivity protection on lead product in Phase III trials.
-
Chair, Patent Litigation & Counseling
It looks like we may have content for your preferred language. Would you like to view this page in English?
Assisted innovator drug company in acquisition requiring expedited review of patent and exclusivity protection on lead product in Phase III trials.